WPC
NEUE

Wedmont Private Capital’s NeueHealth NEUE Stock Holding History

Wedmont Private Capital’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-331
Closed -$5.32K – 529
2023
Q1 		$5.32K Buy
+331
New +$17.1K ﹤0.01% 462

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wedmont Private Capital's NEUE Position: Q2 2023 in Review

Wedmont Private Capital sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 331 shares — an estimated $5.32K sold.

Wedmont Private Capital first reported a position in NEUE in Q1 2023 and held it in 1 quarter. The position peaked at $5.32K in Q1 2023. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • Wedmont Private Capital reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • Wedmont Private Capital sold 331 NeueHealth shares in Q2 2023, an estimated $5.32K.
  • Wedmont Private Capital first reported a position in NeueHealth in Q1 2023 and held it in 1 quarter.
  • Wedmont Private Capital's NeueHealth position peaked at $5.32K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Wedmont Private Capital's 13F filing for Q2 2023, filed 17 Jul 2023.